The prognostic relevance of M2 TAM in MM has been acknowledged by critical clinical studies that associated CD68/CD163 double-positive levels with an increased micro-vessel density and reduced survival, independent of the tumor stage (101–105), as angiogenesis induction is one of the mechanisms through which M2 TAM favors MM progression (104). The gene discussed is CD68; the disease is Miyoshi myopathy.